betaxolol has been researched along with Coronary Disease in 7 studies
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of betaxolol, a cardioselective beta-adrenoceptor antagonist, on ischemic myocardial acidosis were studied in dog hearts, in which the left anterior descending coronary artery was partially occluded for 90 min, and were compared with those of atenolol and propranolol." | 7.68 | Betaxolol, a cardioselective beta-adrenoceptor antagonist, attenuates ischemic myocardial acidosis in dogs. ( Abe, Y; Narimatsu, A; Tobe, A, 1990) |
| "The effects of betaxolol, a cardioselective beta-adrenoceptor antagonist, on ischemic myocardial acidosis were studied in dog hearts, in which the left anterior descending coronary artery was partially occluded for 90 min, and were compared with those of atenolol and propranolol." | 3.68 | Betaxolol, a cardioselective beta-adrenoceptor antagonist, attenuates ischemic myocardial acidosis in dogs. ( Abe, Y; Narimatsu, A; Tobe, A, 1990) |
| "Betaxolol hydrochloride is a beta1-selective antagonist that produces vasodilation in patients with hypertension and ischemic heart disease." | 2.71 | Effect of betaxolol hydrochloride on heart rate variability indices during exercise stress testing in patients with hypertension. ( Abe, Y; Hattori, H; Ishihara, M; Kurita, A; Matsui, T; Nagata, M; Ohsuzu, F; Takase, B, 2005) |
| "Betaxolol has been proven to be a safe and effective antihypertensive agent, and was recently approved for clinical use in the United States for this indication." | 2.67 | Betaxolol: a new long-acting beta 1-selective adrenergic blocker. ( Behrman, D; Frishman, WH; Lazar, EJ; Tepper, D, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takase, B | 1 |
| Abe, Y | 3 |
| Nagata, M | 1 |
| Matsui, T | 1 |
| Hattori, H | 1 |
| Ohsuzu, F | 1 |
| Ishihara, M | 1 |
| Kurita, A | 1 |
| Biamino, G | 1 |
| Schröder, R | 1 |
| Narimatsu, A | 2 |
| Tobe, A | 2 |
| Frishman, WH | 1 |
| Tepper, D | 1 |
| Lazar, EJ | 1 |
| Behrman, D | 1 |
| Narahara, KA | 1 |
| Thompson, CJ | 1 |
| Hazen, JF | 1 |
| Brizendine, M | 1 |
| Mena, I | 1 |
| Brügmann, U | 1 |
| Blasini, R | 1 |
1 review available for betaxolol and Coronary Disease
| Article | Year |
|---|---|
What is the real pharmacological rationale for beta-receptor blocking agents?
Topics: Adrenergic beta-Antagonists; Betaxolol; Coronary Disease; Heart Rate; Humans; Myocardial Contraction | 1983 |
4 trials available for betaxolol and Coronary Disease
| Article | Year |
|---|---|
Effect of betaxolol hydrochloride on heart rate variability indices during exercise stress testing in patients with hypertension.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Betaxolol; Blood Pressure; Coronary Disease; E | 2005 |
Betaxolol: a new long-acting beta 1-selective adrenergic blocker.
Topics: Adult; Arrhythmias, Cardiac; Betaxolol; Biological Availability; Blood Pressure; Clinical Trials as | 1990 |
The effect of beta blockade on single photon emission computed tomographic (SPECT) thallium-201 images in patients with coronary disease.
Topics: Adrenergic beta-Agonists; Algorithms; Betaxolol; Blood Pressure; Coronary Disease; Exercise; Female; | 1989 |
[Comparison of the effect of a selective and a nonselective beta receptor blocker on the ischemic ST segment, lung function and stress-induced decrease in blood glucose].
Topics: Adrenergic beta-Antagonists; Airway Resistance; Angina Pectoris; Betaxolol; Blood Glucose; Blood Pre | 1986 |
2 other studies available for betaxolol and Coronary Disease
| Article | Year |
|---|---|
[Effects of betaxolol, a cardioselective beta-adrenoceptor antagonist, on ischemic myocardial energy and carbohydrate metabolism in dogs].
Topics: Adenine Nucleotides; Adrenergic beta-Antagonists; Animals; Betaxolol; Carbohydrate Metabolism; Coron | 1990 |
Betaxolol, a cardioselective beta-adrenoceptor antagonist, attenuates ischemic myocardial acidosis in dogs.
Topics: Acidosis; Animals; Atenolol; Betaxolol; Blood Pressure; Coronary Circulation; Coronary Disease; Dogs | 1990 |